ResearcherUniversity of HelsinkiActive in the last 2 years
Nora Mattila
Matched on ORCID iD 0000-0003-4007-6555; OpenAlex author ID A5068955655. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/cam4.71954↗
- Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer. Co-author DOI 10.1002/cam4.4397↗
- Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreatic cancer patients. Co-author DOI 10.1016/j.thromres.2020.12.018↗
- Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1177/1076029618779133↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Riitta Lassila · 4 shared papers, 2018–2026 · strength 0.80
- Paper Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Tre… DOI 10.1002/cam4.71954↗
- Paper Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer. DOI 10.1002/cam4.4397↗
- Paper Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreati… DOI 10.1016/j.thromres.2020.12.018↗
- Hanna E. Seppänen · 4 shared papers, 2018–2026 · strength 0.80
- Paper Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Tre… DOI 10.1002/cam4.71954↗
- Paper Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer. DOI 10.1002/cam4.4397↗
- Paper Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreati… DOI 10.1016/j.thromres.2020.12.018↗
- Caj H. Haglund · 4 shared papers, 2018–2026 · strength 0.80
- Paper Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Tre… DOI 10.1002/cam4.71954↗
- Paper Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer. DOI 10.1002/cam4.4397↗
- Paper Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreati… DOI 10.1016/j.thromres.2020.12.018↗
- Annika Eurola · 1 shared paper, 2022 · strength 0.19
- Nigel Mackman · 1 shared paper, 2021 · strength 0.13
- Yohei Hisada · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.